Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PATERSON RESOURCES LTD Director's Dealing 2011

Nov 8, 2011

65618_rns_2011-11-08_81ed5bea-182a-4864-9166-f189e84be58b.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity UNITED OROGEN LIMITED ABN 45 115 593 005

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Zhukov (Zeke) Pervan
Date of last notice 3 November 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest (a) Direct (b) Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. (a) Dr Zhukov Pervan Sole Beneficiary (b) Z P Pty Limited Self managed Super Fund Date of change (a) 8 November 2011 (b) N/A No. of securities held prior to change (a) 337,500 Ordinary Fully Paid Shares and 275,000 Options exercisable at $0.20 each expiring 31 March 2016 (b) 500,000 Ordinary Fully Paid Shares and 450,000 Options exercisable at $0.20 each expiring 31 March 2016 Class (a) Ordinary Fully Paid Shares and Options exercisable at $0.20 each expiring 31 March 2016 (b) Ordinary Fully Paid Shares and Options exercisable at $0.20 each expiring 31 March 2016

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired (a) 162,500 Ordinary Fully Paid Shares (b) Nil Number disposed (a) Nil (b) Nil Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation (a) $4,875.00 for shares (3 cents per share) (b) Nil No. of securities held after change (c) 500,000 Ordinary Fully Paid Shares and 275,000 Options exercisable at $0.20 each expiring 31 March 2016 (d) 500,000 Ordinary Fully Paid Shares and 450,000 Options exercisable at $0.20 each expiring 31 March 2016 Nature of change Example: on-market trade, off-market trade, exercise of options, Off-market trade issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
Date of change N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed N/A
Interest acquired N/A
Interest disposed N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details N/A and an estimated valuation Interest after change N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3